These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
39 related articles for article (PubMed ID: 4105238)
1. A patient-specific treatment model for Graves' hyperthyroidism. Pandiyan B; Merrill SJ; Di Bari F; Antonelli A; Benvenga S Theor Biol Med Model; 2018 Jan; 15(1):1. PubMed ID: 29310665 [TBL] [Abstract][Full Text] [Related]
2. Thiouracil-Forming Bacteria Identified and Characterized upon Porcine In Vitro Digestion of Brassicaceae Feed. Kiebooms JA; Wauters J; Vanden Bussche J; Houf K; De Vos P; Van Trappen S; Cleenwerck I; Vanhaecke L Appl Environ Microbiol; 2014 Dec; 80(23):7433-42. PubMed ID: 25261511 [TBL] [Abstract][Full Text] [Related]
3. Plasma concentrations of methimazole, a metabolite of carbimazole, in hyperthyroid patients. Skellern GG; Stenlake JB; Williams WD; McLarty DG Br J Clin Pharmacol; 1974 Jun; 1(3):265-9. PubMed ID: 22454959 [TBL] [Abstract][Full Text] [Related]
4. Methimazole as a protectant against cisplatin-induced nephrotoxicity using the dog as a model. Vail DM; Elfarra AA; Cooley AJ; Panciera DL; MacEwen EG; Soergel SA Cancer Chemother Pharmacol; 1993; 33(1):25-30. PubMed ID: 8269585 [TBL] [Abstract][Full Text] [Related]
5. The pharmacokinetics of methimazole after oral administration of carbimazole and methimazole, in hyperthyroid patients. Skellern GG; Knight BI; Low CK; Alexander WD; McLarty DG; Kalk WJ Br J Clin Pharmacol; 1980 Feb; 9(2):137-43. PubMed ID: 7356900 [TBL] [Abstract][Full Text] [Related]
7. The effects of altered thyroid state upon responses mediated by atrial muscarinic receptors in the rat. Ishac EJ; Pennefather JN Br J Pharmacol; 1983 Jun; 79(2):451-9. PubMed ID: 6652336 [TBL] [Abstract][Full Text] [Related]
8. Anti-thyroid drugs and lymphocyte function. I. The in vitro effect on blastogenesis and suppressor cell activity. Goldrath N; Eisenstein Z; Bank H; Shoham J Clin Exp Immunol; 1982 Oct; 50(1):55-61. PubMed ID: 6217000 [TBL] [Abstract][Full Text] [Related]
10. Influence of thyroid dysfunction on drug pharmacokinetics. Shenfield GM Clin Pharmacokinet; 1981; 6(4):275-97. PubMed ID: 6166422 [No Abstract] [Full Text] [Related]
11. Pharmacokinetic properties and bioavailability of methimazole. Jansson R; Lindström B; Dahlberg PA Clin Pharmacokinet; 1985; 10(5):443-50. PubMed ID: 4042519 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of methimazole in humans. Hengstmann JH; Hohn H Klin Wochenschr; 1985 Dec; 63(23):1212-7. PubMed ID: 3841378 [TBL] [Abstract][Full Text] [Related]
13. Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references. Pagliaro LA; Benet LZ J Pharmacokinet Biopharm; 1975 Oct; 3(5):333-83. PubMed ID: 1107513 [No Abstract] [Full Text] [Related]
14. Methimazole: its absorption and excretion in man and tissue distribution in rats. Pittman JA; Beschi RJ; Smitherman TC J Clin Endocrinol Metab; 1971 Aug; 33(2):182-5. PubMed ID: 4105238 [No Abstract] [Full Text] [Related]
15. The thyroid accumulation, oxidation and metabolic fate of 35 S-methimazole in the rat. Marchant B; Alexander WD Endocrinology; 1972 Sep; 91(3):747-56. PubMed ID: 4114380 [No Abstract] [Full Text] [Related]
16. The acclumulation of 35 S-antithyroid drugs by the thyroid gland. Marchant B; Alexander WD; Lazarus JH; Lees J; Clark DH J Clin Endocrinol Metab; 1972 May; 34(5):847-51. PubMed ID: 4111035 [No Abstract] [Full Text] [Related]
17. Absorption and excretion of methimazole in man. Dailey GE; Beschi RJ; Smitherman TC; Pittman JA Ala J Med Sci; 1971 Apr; 8(2):220-2. PubMed ID: 4106419 [No Abstract] [Full Text] [Related]